Ignite Creation Date:
2025-12-24 @ 4:16 PM
Ignite Modification Date:
2025-12-24 @ 4:16 PM
Study NCT ID:
NCT02937766
Status:
TERMINATED
Last Update Posted:
2022-04-21
First Post:
2016-10-17
Is Possible Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Study Assessing Injection Pain of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) When Administered Via Subcutaneous Auto-injector vs Intramuscular Injection Via Needle and Syringe in Healthy Post-menopausal Women
Sponsor:
AMAG Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-10-07
Start Date Type:
ACTUAL
Primary Completion Date:
2017-01-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-03-27
Completion Date Type:
ACTUAL
First Submit Date:
2016-10-17
First Submit QC Date:
None
Study First Post Date:
2016-10-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-04-26
Results First Submit QC Date:
None
Results First Post Date:
2018-12-12
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-03-31
Last Update Post Date:
2022-04-21
Last Update Post Date Type:
ACTUAL